If the results come out reasonably satisfactory in March, then I would be VERY keen to see us include infectious diseases into main focus. Ph II is the bottle neck in clinical trials and once we are through Ph II with efti then chances are our research team will only be excited to test the hypothesis in a more general and broader term that; efti, is a first-in-class APC activator which aims to “push the gas” on the body’s immune system. It will be the opportunity to showcase efti in the immune response front beyond oncology ... it will put a hole through the sky!
... but back to earth now ... let's first see what March will bring!
IMM Coronavirus, page-11
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.005(1.23%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 41.0¢ | 41.5¢ | 39.5¢ | $1.576M | 3.906M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2506 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 8079 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |